🇺🇸
United States · US · US:27505-006_52f6e08a-6bd3-3b01-e063-6394a90ae8a6
ONAPGO
Orange BookUNIISPLATC N04BC07
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerMDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc
CountryUS (United States)
ATC codeN04BC07
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1127505006055 CARTRIDGE in 1 CARTON (27505-006-05) / 20 mL in 1 CARTRIDGE (27505-006-01)
Annotations
UNII (FDA Substance ID)
F39049Y068
APOMORPHINE HYDROCHLORIDE
RxCUI 71225
Orange Book
N214056
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "F39049Y068",
"rxcui": "71225",
"inchikey": "CXWQXGNFZLHLHQ-DPFCLETOSA-N",
"display_name": "APOMORPHINE HYDROCHLORIDE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBCUTANEOUS",
"spl_meta": {
"f3552b6e-5ae7-4993-aa1a-e399c4a7080a": {
"match": "brand_token",
"title": "ONAPGO (APOMORPHINE HYDROCHLORIDE) INJECTION, SOLUTION [MDD US OPERATIONS, LLC, A SUBSIDIARY OF SUPERNUS PHARMACEUTICALS, INC]",
"spl_version": "17",
"published_date": "2026-06-01"
}
},
"productid": "27505-006_52f6e08a-6bd3-3b01-e063-6394a90ae8a6",
"productndc": "27505-006",
"dosage_form": "INJECTION, SOLUTION",
"orange_book": {
"appl_no": "214056",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "98MG/20ML (4.9MG/ML)",
"product_no": "001",
"approval_date": "Feb 3, 2025"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "APOMORPHINE HYDROCHLORIDE",
"proprietary_name": "ONAPGO",
"active_ingred_unit": "mg/mL",
"application_number": "NDA214056",
"marketing_category": "NDA",
"nonproprietary_name": "Apomorphine hydrochloride",
"start_marketing_date": "20250204",
"active_numerator_strength": "4.9"
}Related drugs
Other records sharing ATC code N04BC07.
- 🇨🇭APO-goSpirig HealthCare AG
- 🇨🇭APO-goSpirig HealthCare AG
- 🇨🇭APO-go
- GBAPO-go 20mg/2ml solution for injection ampoulesBritannia Pharmaceuticals Ltd
- NLAPO-go 5 mg/ml, oplossing voor infusie in een voorgevulde spuitStada Arzneimittel AG
- GBAPO-go 50mg/5ml solution for injection ampoulesBritannia Pharmaceuticals Ltd
- IEAPO-go AMPOULES 10 mg/ml Solution for Injection or Infusion *Abbreviated to APO-go in the textStada Arzneimittel AG
- NLAPO-go Ampullen 10 mg/ml oplossing voor injectie of infusieStada Arzneimittel AG
Access this data programmatically
Query ONAPGO and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.